Skip to main content

Advertisement

SpringerLink
Log in

ASO Visual Abstract: Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Department of Urology, Medical University of Vienna, Vienna, Austria

    Keiichiro Mori MD, Victor M. Schuettfort MD, Satoshi Katayama MD, Ekaterina Laukhtina MD, Benjamin Pradere MD, Fahad Quhal MD, Reza Sari Motlagh MD, Hadi Mostafaei MD, Nico C. Grossmann MD, Pawel Rajwa MD, Irene Resch MD, Harun Fajkovic MD, Marco Moschini MD, David D’andrea MD, Mohammad Abufaraj MD & Shahrokh F. Shariat MD

  2. Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

    Keiichiro Mori MD & Shin Egawa MD

  3. Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    Victor M. Schuettfort MD

  4. Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

    Satoshi Katayama MD

  5. Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia

    Ekaterina Laukhtina MD & Shahrokh F. Shariat MD

  6. Department of Urology, King Fahad Specialist Hospital, Dammam, Saudi Arabia

    Fahad Quhal MD

  7. Men’s Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Reza Sari Motlagh MD

  8. Research Center for Evidence Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

    Hadi Mostafaei MD

  9. Department of Urology, University Hospital Zurich, Zurich, Switzerland

    Nico C. Grossmann MD

  10. Department of Urology, Medical University of Silesia, Zabrze, Poland

    Pawel Rajwa MD

  11. Department of Surgery, S.H. Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, China

    Jeremy Y. C. Teoh MD

  12. Klinik für Urologie, Luzerner Kantonsspital, Lucerne, Switzerland

    Marco Moschini MD

  13. Research Division of Urology, Department of Special Surgery, The University of Jordan, Amman, Jordan

    Mohammad Abufaraj MD & Shahrokh F. Shariat MD

  14. Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Canada

    Pierre I. Karakiewicz MD

  15. Department of Urology, University of Texas Southwestern, Dallas, TX, USA

    Yair Lotan MD & Shahrokh F. Shariat MD

  16. Department of Urology, Weill Cornell Medical College, New York, NY, USA

    Douglas Scherr MD & Shahrokh F. Shariat MD

  17. Department of Pathology, Medical University of Vienna, Vienna, Austria

    Eva Compérat MD

  18. Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic

    Shahrokh F. Shariat MD

  19. Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria

    Shahrokh F. Shariat MD

Authors
  1. Keiichiro Mori MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Victor M. Schuettfort MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Satoshi Katayama MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ekaterina Laukhtina MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Benjamin Pradere MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fahad Quhal MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Reza Sari Motlagh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hadi Mostafaei MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Nico C. Grossmann MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Pawel Rajwa MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jeremy Y. C. Teoh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Irene Resch MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Harun Fajkovic MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Marco Moschini MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. David D’andrea MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Mohammad Abufaraj MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Pierre I. Karakiewicz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Yair Lotan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Douglas Scherr MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Shin Egawa MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Eva Compérat MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. Shahrokh F. Shariat MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

European Association of Urology–Young Academic Urologists Urothelial Carcinoma Working Group (EAU-YAU)

Corresponding author

Correspondence to Shahrokh F. Shariat MD.

Ethics declarations

Disclosure

The authors certify that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript are reported as follows. Shahrokh Shariat owns or co-owns the following patents: Methods to determine prognosis after therapy for prostate cancer (granted 2002-09-06); Methods to determine prognosis after therapy for bladder cancer (granted 2003-06-19); Prognostic methods for patients with prostatic disease (granted 2004-08-05); and Soluble Fas: urinary marker for the detection of bladder transitional cell carcinoma (granted 2010-07-20). He has also undertaken a consulting or advisory role for Astellas, AstraZeneca, Bayer, BMS, Cepheid, Ferring, Ipsen, Jansen, Lilly, MSD, Olympus, Pfizer, Pierre Fabre, Roche, Sanochemia, Sanofi, Takeda, Urogen, and Wolff. Yair Lotan has undertaken a consulting role for Nanorobotics (commencing May 2021), C2i genomics (commencing October 2020), Fergene, Abbvie (commencing June 2020), Cleveland Diagnostics, Nucleix, Ambu, Seattle Genetics (agreement December 2020), Hitachi (January 2020), Ferring Research (February 2020), Verity Pharmaceuticals, Virtuoso Surgical (commenced March 2021), Nanorobot (commenced June 2021), and Stimit (commenced July 2021), and has undertaken a consultant/advisory role for Photocure (scientific study or trial), Astra-Zeneca, and Merck. He has also undertaken research work for Abbott (scientific study or trial, completed March 2019), Cepheid (scientific study or trial), Pacific Edge (scientific study or trial), FKD (scientific study or trial, completed 2019), MDxHealth (scientific study or trial), Biocancell (scientific study or trial, ended January 2020), GenomeDx Biosciences, Inc. (scientific study or trial), and Storz (scientific study). Keiichiro Mori, Victor M. Schuettfort, Satoshi Katayama, Ekaterina Laukhtina, Benjamin Pradere, Fahad Quhal, Reza Sari Motlagh, Hadi Mostafaei, Nico C. Grossmann, Pawel Rajwa, Jeremy Y.C. Teoh, Irene Resch, Harun Fajkovic, Marco Moschini, David D’andrea, Mohammad Abufaraj, Pierre I. Karakiewicz, Douglas Scherr, Shin Egawa, and Eva Compérat have declared no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mori, K., Schuettfort, V.M., Katayama, S. et al. ASO Visual Abstract: Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy. Ann Surg Oncol 29, 5319–5320 (2022). https://doi.org/10.1245/s10434-022-11742-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-11742-7

Search

Navigation